Experimental cell therapy injected into eyes to fight blinding disease
Disease control
Recruiting now
This study is testing the safety of a single injection of an experimental cell therapy called jCell into the eye of adults with retinitis pigmentosa (RP), a genetic eye disease that causes vision loss. Over 60 participants will be randomly assigned to receive either the real inje…
Phase: PHASE2 • Sponsor: jCyte, Inc • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC